Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATryn in Hereditary Antithrombin Deficiency
NCT00110513Phase 3Completed
- Sponsor
- rEVO Biologics
- Start
- Apr 2005
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of antithrombin III in hereditary antithrombin deficiency, sponsored by rEVO Biologics. Started Apr 2005; status: completed.
02
Drugs
antithrombin III
03
Conditions
hereditary antithrombin deficiency
Beyond the preview
Go deeper on NCT00110513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110513.